Obesity Trial, Recruiting NCT04873258 Sponsor: Richmond Research Institute Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT04873258
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 80 years old at the time of signing the consent form, either male or female
  • People who are willing and able to sign and date a written consent form agreeing to take part
  • People who are able and willing to follow all of the trial's procedures and requirements throughout the study

For one part of the trial (Part B) only, there is an additional requirement:

  • People who have a known diagnosis of a liver condition called MASLD (a type of fat-related liver disease), confirmed either by a GP's recorded diagnosis or by a specialist liver scan (Fibroscan or ultrasound)

Who may not be able to join:

  • People with alcoholic liver disease, or scarring of the liver (cirrhosis) caused by any condition, including metabolic conditions or viral hepatitis
  • People with other serious liver conditions in their history, such as liver cancer, high blood pressure in the liver's blood vessels, or diseases that have spread into the liver
  • People who drink more than 30 units of alcohol per week
  • People who have an implanted heart device (such as a pacemaker or defibrillator)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jorg Taubel, MD, Richmond Pharmacology Limited

Phone: +44 (0)20 7042 5800

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Richmond Research Institute
Registry
ClinicalTrials.gov
Start date
27 September 2019
Est. completion
31 December 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Establishment of Classification Tool for Use in Clinical Trials

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov